Good to have you back Grip. Your negative sentiment seems to have reverse impact on the SP. Hope you hang in there.

I agree. It is obvious. We are so close to news that will make this rip.

So four patients that are fighting for their lives in NY have been injected with Leronlimab. Why would a healthcare professional make this decision?

I’ll tell you why. Because the overseeing Doctor had a lengthy scientific discussion with Patterson about the MOA, results in other indications, safety profile, and ability to predict effectiveness based on CCR5 screening.

Having an opinion is one thing. Calling this molecule a scam at this point in the game is just plain ignorance. That is why you have ONE follower.

You may feel like him, however you have a ways to go before perception meets reality - ONE follower is quite a wake up call.

I’ll tell you one thing that’s going to zero. This board. This is has become a home for the homeless. They have pitched their tents and have their cardboard signs out front and center around the clock.

It’s a sickness. I recommend doubling the six foot rule.

It is rare that one is subject to

Get ready for many more. Appreciate you counting. Music to my ears.

He’s clueless and that’s being complimentary.

Quack Quack. There goes the Ego Duck.

You know what game? How to go broke?

https://seekingalpha.com/news/3553237-fda-oks-emergency-ind-for-use-of-cytodyns-leronlimab-in-covidminus-19

Buffoon is an understatement.

Keep on cooking Real. Your on a roll. Your menu has put you out of business.

The question is did you check the address?

Once again this address is basically attached to UCSF Medical Center. You thought you had something you could use with that address and you stepped right into deep s#%t because you didn’t peel the later of the onion back far enough to understand why Quest is located where it is.

That is the foundation of your dialogue here. A sound bite here and there and a very inaccurate description of what is actually transpiring with this company.

I wouldn’t normally not take the time to respond do your gibberish but this post today is so far off base and in my backyard the truth has to be known.

Your credibility is at zero and dropping.

Real Temperature.

He just cooked up a helluva batch this morning. I guess UCSF Med Center and Quest is located in a car parts neighborhood. And yeah our CEO and CMO speak the same language and that’s a red flag.

That’s some Real home cooking.

“Lalezari and Nader are related and they speak same language as well”

So why is this relevant, are you a racist.

FYI Real, Quest is located next door to the prestigious UCSF Medical Center. I live in the SF Bay Area and know the location well. Can’t think of a better location.

Can’t argue with your frustration. I’ve had my issues with Nader, who concerns me with his persona and communication skills. I’m in because the science is just to compelling and will not be ignored. 2020 will tell the story and I like the risk/reward going forward.

GLTU

Below I meant BTD not BLA.

Keep in mind while we don’t know the current status regarding the BLA (despite some here thinking they know) I think it is reasonable to assume the FDA will most likely require more patients. That’s ok because the increased dosage is only going to further validate what we already know.

BLA will not be a huge mover but will validate CYDY as a company approaching revenue.

BTD approval would be a horse of a different color. That’s a major mover —pure speculation $2 plus.

Keep in mind while we don’t know the current status regarding the BLA (despite some here thinking they know) I think it is reasonable to assume the FDA will most likely require more patients. That’s ok because the increased dosage is only going to further validate what we already know.

This and much more is all coming to a head in 2020. Its the best of times from my perspective.

What are you shorts going to do when the BLA is filed? You act as if this is all a make believe play. Regardless of it happening next week or in the coming weeks it’s going to happen. That’s not rocket science just fact. Science is solid, data will continue to stack, non dilutive deal will be signed, BTD will come through in the coming months, China and Taiwan deal is on the table, and that’s the short list...no pun intended. Are you guys ignorant enough to think none of this will transpire. It’s clear your going to have to start figuring out where next to take your copy and paste surface story.

When a company like CytoDyn comes out with excellent news day after day and has the potential to be the next best thing in coronavirus treatments in the near term and no one pays attention, blame is going to fall squarely on the SHORTS. It was evident last Friday at the height of coronavirus fears when the company announced an investor conference call update headline with a seemingly endless supply of positive news forthcoming. After the announcement hit the wire investors started piling on to buy it then the rally ran into a brick wall and started going lower again. The headline highlighted the Phase 2 trial for COVID-19, BLA update, BTD, Basket trial filing, and licensing opportunities. It was clear that this was going to be a very positive update. The conference call delivered but the reaction is still tepid as the bulls and the bears are duking it out. Right now the shorts can still cling to the hope that CytoDyn hasn’t filed their BLA yet and will not complete the filing until the end of March, but investors are also to blame or asleep at the switch here because in by the beginning of the month the FDA could come through with a Breakthrough Therapy Designation (BTD) approval worth billions of dollars.

Well, I see you’ve been here since 2013 as have I. Vision and knowledge are the foundational pillars needed to endure an investment of this magnitude. Those two together produce confidence which you have lost. One without the other will result in the decision you have just made. Hopefully you can regain your confidence to keep your other half of your shares.

The question is will you slit your wrists when the SP is at $5 at the end of the year and heading North? My experience in life is people give up when they are inches away from the gold. If the science was headed into a ditch I’d understand - to the contrary factually the science is gaining momentum and will be revealed in its entirety.

GLTU

This space has turned into a cesspool thanks to a few short sighted agenda driven posters. Every day is a repeat of the same junk. It’s similar to baby chicks that wake up squawking in their nests every morning needing to be fed. These chicks feed themselves.

A17, I predicted your interpretation. Can we reel this back a bit and understand the process by which a drug obtains the coveted FDA BTD approval?

Like everything in business it’s a negotiation process. Anyone with half a brain would understand that the FDA was going to require more data; more patients and more confirmation. I applaud Nader for pushing the envelope and positioning Leronlimab on the radar. Just keep the clinical results coming and the dam will break.

In spite of your bitterness your going to be rewarded. Life is full of surprises.

Quack quack.

Shame on you Duck. Get a life.

Yes Misiu very shameful. As I have said I don’t have a problem with differing opinion but I do have a problem with disrespectful self serving falsities. It really is the bottom of the barrel.

After reading the last 40 posts it is clear we have two posters that will never understand the fundamentals of what is taking place with Leronlimab. That’s ok. Not everybody has that capacity. Heck two out of thousands is pretty impressive actually. The rub is the redundant surface story that is copied and pasted relentlessly. It’s time to use the ignore button.

Maybe, who knows?

My take is they are not worried about $ because they have so many options. They also know there are immediate catalysts that can double or even triple the SP that would completely change $ options and terms. That’s what makes me laugh about the usual suspects peddling the doom and gloom monologue.

There is so much upside that all bets are off at this point. It doesn’t take a whole lot of smarts to see the positioning that is taking place.

One PR away from a big jump. And yes maybe we wake up to a buy out although I think we are best positioned to maximize our return after an organic uplist. That is where my sites are now.

Yes Tony, great things in the works with limited visibility and credibility on the OTC.

If, and I mean IF the data from the cancer trials remains consistent word will get out and we will be off the OTC trading on the NYSE or NASDAQ by years end.

What I like is the loading up of patients in the basket trial and escalation of dosing that is going to begin. Results can only get better not worse with 525ml and 725ml. In 3-6 months we will have 40 patients staggered in the mTNBC and Basket Trial with results ranging from a month on Leronlimab to close to a year.

BTD may not be granted in the coming weeks because the FDA needs more patients. Well they are going to get more patients and rapidly. BTD approval along with completing BLA will completely change this investment forever. We are oh so close and Nader knows it.

I don’t think it is any secret that the next three months are going to go a long way in terms of the success of this investment.

As you can see I’m not even factoring in the Coronavirus card which is a mover all by itself.

How anybody in their right mind would short this stock at this juncture is beyond my logic.

GL.

Great news Eng. That would mean the discounted shares being sold are creating a bargain for those buying at $1.10. You so smart.

I could give a flip about the short interest or theory.

Let’s be straight your here to short the stock and believe it is headed South. I’m Long and believe it’s headed North.

Your comments about delays and nothing happening are simply your attempt to invoke fear. I have never seen so many near term catalysts moving forward with a company this size. The $500M market cap is what the market says CYDY is worth at this particular point in time.

I would argue CYDY is in a strong position to triple MC over the next few months. The catalysts are there and within reach. BLA is a done deal so that broken record attack is out the window. BTD, Licensing Deals, non dilutive financing deals up to $100M on the table, term sheets with both Taiwan and China in play, Basket Trial on the move with 20 new patients in next couple of months, stellar cancer results continue to roll in and MOA is gaining traction, Coronavirus IND basically completed... yeah this is a company that has nothing. Are you kidding me.

I’m objective but your redundant surface story is flat. If I were looking to short I’d need to see a hole lot more meat...any meat for that matter.

Triple digits not even in my wildest dreams. I’m a realist and play the devils advocate in my decision making. Pathway is there to organic uplist by EOY. That’s as far down the road as I am willing to go until we get there.

Not once did hear $100.

Come on Duck. That’s all you got. So weak.

A17. Please don’t place me or most here in the triple digit club.

I’m not hearing Nader pump that either so why are you? If things continue to roll out an organic uplist by the EOY is a very real possibility. One step at a time. That equates to a starting point on either the NYSE or NASDAQ of $3-$5 and then we will see where this goes.

The pathway is there but that takes vision. Vision combined with passion and substance is how great things happen.

A17. I’ve been here a long time as have you. You are like stuck in your s#%t. So bad you wouldn’t know what to do when a gift horse looks you in the mouth. Will you be bitter when you get your pay day. I think so.., it’s just who you have become. Dig out fool and enjoy the ride.

Give it a rest. You are grinding your redundant self serving pitch. Talk about deception, that’s what you do for a living. Your fighting a loosing battle - definitely going to loose the war.

What a great call. Couldn’t be more bullish.

I really don’t understand how anyone could listen to this call and not be impressed. Very informative in that the investor knows exactly where they stand and what can be expected.

Nader is juggling a lot of balls and I must say doing a fantastic job.

$ is not an issue. Plenty of options up to $100M and not issuing more shares.

I agree with the fact that Nader really doesn’t want a $5B offer as the probability of increased valuation is quite high. We have the gold so why give it away for ten cents on the dollar.

The data will continue to stack up and that will be the anchor at the end of the day.

BLA filing is a done deal, period.

I was looking for urgency. That is what I heard on the call. Full speed ahead on all fronts. Quite likely we will be selling Leronlimab to Taiwan and China in 2020 and generating revenue regardless of FDA approval thanks to Patterson opening the doors.

Shorts still selling thin air surface story. Keep grinding guys. I can feel the desperation in your posts.